BTS
FBIO icon

BB&T Securities’s Fortress Biotech FBIO Stock Holding History

BB&T Securities’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,040
Closed -$46K – 1600
2018
Q2 		$46K Hold
1,040
– – ﹤0.01% 1521
2018
Q1 		$70K Hold
1,040
– – ﹤0.01% 1471
2017
Q4 		$62K Hold
1,040
– – ﹤0.01% 1423
2017
Q3 		$68K Buy
+1,040
New +$70.1K ﹤0.01% 1375

Other funds holding FBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

BB&T Securities's FBIO Position: Q3 2018 in Review

BB&T Securities sold out of Fortress Biotech (FBIO) in Q3 2018, closing a stake of 1,040 shares — an estimated $46K sold.

BB&T Securities first reported a position in FBIO in Q3 2017 and held it in 4 quarters. The position peaked at $70K in Q1 2018. 65 funds tracked by Wall St. Rank hold FBIO as of Q3 2018.

  • BB&T Securities reported no remaining Fortress Biotech position as of Q3 2018 after selling out during the quarter.
  • BB&T Securities sold 1,040 Fortress Biotech shares in Q3 2018, an estimated $46K.
  • BB&T Securities first reported a position in Fortress Biotech in Q3 2017 and held it in 4 quarters.
  • BB&T Securities's Fortress Biotech position peaked at $70K in Q1 2018.
  • 65 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2018.

Based on BB&T Securities's 13F filing for Q3 2018, filed 14 Nov 2018.